While promising, these studies are small and short-term
In these terms, indicative is the rat corneal ulcer successfully closed with the BPC 157 eye drops and maintained corneal transparency (Figure 14) (Masnec et al., 2015)
Unlike traditional methods, IV treatments offer a more immediate solution to dehydration for swifter recovery
Research use differs from medical use because a laboratory or preclinical study does not establish an approved human treatment
Novel compounds and therapeutic approaches exhibit restricted clinical efficacy attributable to factors such as short half-life, in vivo stability, and challenges associated with blood-brain barrier penetration, among others (177)
Gradual improvement is seen between 8 and 12 weeks by many people, with the tone balance being more consistent after 3-6 months